228 related articles for article (PubMed ID: 20561454)
1. [Research advance on adaptive immune therapy with natural killer cells--review].
Chen GH; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):798-802. PubMed ID: 20561454
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation.
Patil S; Schwarer T
Intern Med J; 2009 Oct; 39(10):639-47. PubMed ID: 19686544
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances of studies on interaction of natural killer cells and fungi].
Ma XX; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1334-8. PubMed ID: 22040999
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell development and biology.
Farag SS; Caligiuri MA
Blood Rev; 2006 May; 20(3):123-37. PubMed ID: 16364519
[TBL] [Abstract][Full Text] [Related]
6. The role of natural killer cells in hematopoietic stem cell transplantation.
Tsirigotis PD; Resnick IB; Shapira MY
Ann Med; 2012 Mar; 44(2):130-45. PubMed ID: 21410396
[TBL] [Abstract][Full Text] [Related]
7. Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer.
Kennedy PR; Felices M; Miller JS
Stem Cell Res Ther; 2022 Apr; 13(1):165. PubMed ID: 35414042
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
Terme M; Ullrich E; Delahaye NF; Chaput N; Zitvogel L
Nat Immunol; 2008 May; 9(5):486-94. PubMed ID: 18425105
[TBL] [Abstract][Full Text] [Related]
9. Can NK cells be a therapeutic target in human cancer?
Chan CJ; Andrews DM; Smyth MJ
Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
11. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant.
Velardi A; Ruggeri L; Mancusi A
Curr Opin Hematol; 2012 Jul; 19(4):319-23. PubMed ID: 22555394
[TBL] [Abstract][Full Text] [Related]
12. Infusions of allogeneic natural killer cells as cancer therapy.
Leung W
Clin Cancer Res; 2014 Jul; 20(13):3390-400. PubMed ID: 24987108
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell adoptive immunotherapy: Coming of age.
Baggio L; Laureano ÁM; Silla LMDR; Lee DA
Clin Immunol; 2017 Apr; 177():3-11. PubMed ID: 26883680
[TBL] [Abstract][Full Text] [Related]
14. [NK cell surface receptors and their research progress - review].
Liu S; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1034-8. PubMed ID: 22931679
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.
Lamb MG; Rangarajan HG; Tullius BP; Lee DA
Stem Cell Res Ther; 2021 Mar; 12(1):211. PubMed ID: 33766099
[TBL] [Abstract][Full Text] [Related]
17. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
18. Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?
Nguyen S; Béziat V; Roos-Weil D; Vieillard V
J Innate Immun; 2011; 3(4):383-94. PubMed ID: 21411973
[TBL] [Abstract][Full Text] [Related]
19. New directions in natural killer cell-based immunotherapy of human cancer.
Farag SS; Fehniger TA; Becknell B; Blaser BW; Caligiuri MA
Expert Opin Biol Ther; 2003 Apr; 3(2):237-50. PubMed ID: 12662139
[TBL] [Abstract][Full Text] [Related]
20. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
